LifeMD (LFMD) Azione Prezzo
LifeMD Prezzo
Il fatturato è cresciuto a un tasso composto del 39,6% annuo negli ultimi 15 anni, raggiungendo 194,06 Mio. USD. Il margine netto di LifeMD si attesta al -3,7%, in aumento rispetto al -65,6% di alcuni anni fa. Gli analisti fissano un target di prezzo mediano di 8,00 USD, ovvero il 207,1% sopra il prezzo attuale. Su 14 analisti, 13 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
LifeMD Prezzo delle azioni
LifeMD Azione e analisi azionaria
Domande frequenti sull'azione LifeMD
LifeMD Inc is a leading telehealth company that focuses on providing customized and convenient healthcare solutions to its customers. The business model of LifeMD Inc revolves around offering telemedicine consultations, prescription medications, and direct-to-consumer laboratory testing services. By leveraging advanced technology and a team of experienced healthcare professionals, LifeMD Inc aims to improve access to high-quality healthcare for individuals seeking personalized treatment options.
LifeMD Inc is primarily active in the telemedicine and healthcare industries.
The main competitors of LifeMD Inc in the market include companies like Teladoc Health, Amwell, and Hims & Hers. These companies also provide telemedicine and telehealth services, offering similar solutions to LifeMD Inc. However, LifeMD Inc distinguishes itself by focusing on a comprehensive approach to men's and women's healthcare needs, with a range of services including telemedicine consultations, hormone therapy, and at-home testing kits. LifeMD Inc aims to provide personalized healthcare solutions that cater specifically to individuals' wellness goals.
LifeMD Inc. is a healthcare technology company founded in 2020. It specializes in telemedicine and virtual care solutions, offering a wide range of personalized healthcare services. LifeMD Inc. has garnered recognition for its innovative platform that connects patients with licensed healthcare providers remotely. The company's mission is to improve access to quality healthcare by leveraging technology. LifeMD Inc. aims to deliver personalized, convenient, and affordable healthcare services to individuals across various medical specialties. With its cutting-edge telemedicine platform, the company is revolutionizing the way people receive medical care, enabling them to access top-notch healthcare services from the comfort of their homes.
LifeMD Inc has achieved several significant milestones since its inception. The company has gained recognition for its innovative telemedicine platform, providing accessible and affordable healthcare solutions to patients. In addition, LifeMD has successfully expanded its product offerings, introducing a comprehensive range of medical treatments and therapies tailored to various health concerns. The company has also demonstrated strong financial growth, realizing increased revenues and expanding its customer base. With its commitment to revolutionizing the healthcare industry, LifeMD Inc continues to deliver cutting-edge solutions and improve the overall well-being of individuals around the world.
LifeMD Inc is primarily present in the United States.
LifeMD Inc represents a set of core values and a strong corporate philosophy. With a focus on improving the health and well-being of individuals, LifeMD is committed to offering innovative telemedicine and virtual care solutions. The company prioritizes patient-centered care, convenience, and accessibility, aiming to revolutionize the way healthcare is delivered. LifeMD's corporate philosophy revolves around providing personalized and comprehensive medical services through its team of experienced healthcare professionals. By leveraging advanced technology and a patient-centric approach, LifeMD Inc is dedicated to enhancing the quality of healthcare for its customers and making a positive impact on their overall wellness.
Gli analisti fissano attualmente un prezzo obiettivo medio di 7,67 USD per l’azione LifeMD (mediana: 8,00 USD), pari a +194,4 % rispetto all’ultimo prezzo. Il consenso si basa su 14 giudizi di analisti.
14 analisti valutano attualmente l’azione LifeMD: 13 raccomandano l’acquisto, 1 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per LifeMD ricavi pari a 207,67 Mio. USD e un utile per azione di -0,53 USD.
Convertita al tasso di cambio attuale, l’azione LifeMD quota 2,33 EUR (2,61 USD).
L’azione LifeMD (LFMD) è quotata su 1 borse, tra cui: NASDAQ (LFMD).
The company LifeMD Inc is a US-American company specialized in providing telemedicine services. They offer various medical fields such as general medicine, gynecology, dermatology, urology, and psychiatry. The company's goal is to provide a fast, convenient, and cost-effective way to access medical advice and treatment. They have built a network of licensed doctors who are available for video chat or phone calls. Customers can book appointments through the LifeMD app or website and speak with a doctor within minutes. They also offer in-person visits at LifeMD clinics or in-home visits. In addition to telemedicine services, LifeMD also provides nutrition counseling, fitness and health programs, and a wide range of supplements made from natural ingredients. They focus on providing anti-aging products and services such as hormone replacement therapies, hair plasma therapies, and skincare products. LifeMD operates on a monthly subscription model, where customers can access all available services for a monthly fee. Prices for subscriptions range from $49.99 for a basic membership to $249.99 for a premium membership. LifeMD stands out from other providers by offering comprehensive digital healthcare services, allowing customers to access medical care from anywhere. It is a convenient alternative for people who live far from doctors or have limited time for appointments. Especially during the COVID-19 pandemic, LifeMD provides a safe environment for medical advice and care. In summary, LifeMD offers an innovative and holistic concept for healthcare. With a wide range of medical, nutrition, and anti-aging services, the company can meet individual needs and ensure optimal care. Thanks to the monthly subscription model, LifeMD is accessible to a broad target audience and offers a flexible and cost-effective alternative to traditional healthcare.
Il attesa fatturato di LifeMD ammonta a 207,67 Mio. USD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di LifeMD ammonta a -24,96 Mio. USD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di LifeMD è attualmente -4,88. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione LifeMD.
Il rapporto prezzo/fatturato (P/S) di LifeMD è attualmente 0,59. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione LifeMD.
Il Quality Score AlleAktien per LifeMD è 3/10.
L'ISIN di LifeMD è US53216B1044. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il ticker di LifeMD è LFMD. Con questo simbolo di borsa vengono negoziate le azioni LifeMD in borsa.
Azione LifeMD
Gruppo di pari di LifeMD
LifeMD Ticker
LifeMD FIGI
Altre metriche e analisi di LifeMD in Deep Dive.
La nostra analisi azionaria dell'azione LifeMD include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di LifeMD. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: